Search Results - Robert Roskoski Jr

Targeted and cytotoxic inhibitors used in the treatment of lung cancers by Robert Roskoski Jr

Connect to this object online.

Properties of FDA-approved small molecule protein kinase inhibitors: A 2024 update by Robert Roskoski, Jr

Connect to this object online.

Janus kinase (JAK) inhibitors in the treatment of neoplastic and inflammatory disorders by Robert Roskoski, Jr

Connect to this object online.

Cost in the United States of FDA-approved small molecule protein kinase inhibitors used in the treatment of neoplastic and non-neoplastic diseases by Robert Roskoski, Jr

Connect to this object online.

Small molecule protein kinase inhibitors approved by regulatory agencies outside of the United States by Robert Roskoski Jr

Connect to this object online.

Deucravacitinib is an allosteric TYK2 protein kinase inhibitor FDA-approved for the treatment of psoriasis by Robert Roskoski, Jr

Connect to this object online.

Rule of five violations among the FDA-approved small molecule protein kinase inhibitors by Robert Roskoski, Jr

Connect to this object online.

Combination immune checkpoint and targeted protein kinase inhibitors for the treatment of renal cell carcinomas by Robert Roskoski, Jr

Connect to this object online.